Standard Family Office’s AbbVie ABBV Stock Holding History

Standard Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.5K	Hold	324	–	–	0.07%	22
2025 Q4	$74K	Hold	324	–	–	0.08%	21
2025 Q3	$75K	Hold	324	–	–	0.08%	20
2025 Q2	$60.1K	Hold	324	–	–	0.07%	22
2025 Q1	$67.9K	Sell	324 -243	-43%	-$47.2K	0.09%	21
2024 Q4	$101K	Hold	567	–	–	0.12%	23
2024 Q3	$112K	Hold	567	–	–	0.14%	25
2024 Q2	$97.3K	Hold	567	–	–	0.13%	26
2024 Q1	$103K	Buy	+567	New	+$97.7K	0.14%	26
2022 Q4	–	Sell	-980	Closed	-$132K	–	12
2022 Q3	$132K	Hold	980	–	–	0.06%	59
2022 Q2	$150K	Buy	+980	New	+$150K	1.49%	20
2022 Q1	–	Sell	-829	Closed	-$112K	–	74
2021 Q4	$112K	Buy	+829	New	+$97.9K	0.99%	27
2021 Q3	–	Sell	-559	Closed	-$63K	–	68
2021 Q2	$63K	Hold	559	–	–	0.01%	226
2021 Q1	$60K	Hold	559	–	–	0.01%	245
2020 Q4	$60K	Buy	+559	New	+$53.7K	0.01%	248

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Standard Family Office's ABBV Position: Q1 2026 in Review

Standard Family Office held its AbbVie (ABBV) position steady in Q1 2026 at 324 shares worth $70.5K. The position accounts for 0.07% of the portfolio, ranked #22.

Standard Family Office first reported a position in ABBV in Q4 2020 and has held it in 15 quarters since. The position peaked at $150K in Q2 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Standard Family Office held 324 shares of AbbVie worth $70.5K as of Q1 2026.
Standard Family Office left its AbbVie share count unchanged in Q1 2026.
AbbVie made up 0.07% of Standard Family Office's portfolio in Q1 2026, its #22 holding.
Standard Family Office first reported a position in AbbVie in Q4 2020 and has held it in 15 quarters since.
Standard Family Office's AbbVie position peaked at $150K in Q2 2022.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Standard Family Office's 13F filing for Q1 2026, filed 14 May 2026.